UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | C000000290 |
|---|---|
| Receipt number | R000000369 |
| Scientific Title | Phase II study of imatinib mesylate for treatment of Philadelphia Chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) in children: A Japanese Cooperative Trial |
| Date of disclosure of the study information | 2005/12/01 |
| Last modified on | 2011/07/06 00:41:49 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2005/11/24 12:36:44 | ||
| 2 | Update | 2006/02/07 00:40:25 | Study type Basic design Randomization Blinding Control No. of arms Purpose of intervention Type of intervention Interventions/Control_1 Interventions/Control_1 |
|
| 3 | Update | 2006/02/07 00:42:09 | Trial characteristics_2 |
|
| 4 | Update | 2006/02/07 00:56:35 | Institute Institute Organization Organization Organization1 Address1 Tel1 Email1 |
|
| 5 | Update | 2007/11/26 16:12:17 | Organization Organization |
|
| 6 | Update | 2009/06/15 15:42:03 | Recruitment status |
|
| 7 | Update | 2011/07/06 00:41:49 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
